SEC Info - Iovance Biotherapeutics, Inc. - ‘8-A12B/A’ on 7/26/17

SEC Info℠

Home

Help

Please Sign In

Iovance Biotherapeutics, Inc. – ‘8-A12B/A’ on 7/26/17

On: Wednesday, 7/26/17, at 6:46pm ET · As of: 7/27/17 · Accession #: 1144204-17-38435 · File #: 1-36860

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/27/17  Iovance Biotherapeutics, Inc.     8-A12B/A    7/26/17    1:45K                                    Vintage/FA

Amendment to Registration of a Class of Securities — Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B/A    Amendment to Registration of a Class of Securities  HTML     28K

Filing Submission 0001144204-17-038435 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 45K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20170727-050419	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20170727-050419	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20170726-184621	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001144204-17-038435
<TYPE>				8-A12B/A
<PUBLIC-DOCUMENT-COUNT>		1
<FILING-DATE>			20170727
<DATE-OF-FILING-DATE-CHANGE>	20170726

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		IOVANCE BIOTHERAPEUTICS, INC.
<CIK>				0001425205
<ASSIGNED-SIC>			2836
<IRS-NUMBER>			753254381  ⇒ 75-3254381
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-A12B/A
<ACT>				34
<FILE-NUMBER>			001-36860
<FILM-NUMBER>			17984014
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			999 SKYWAY ROAD
<STREET2>			SUITE 150
<CITY>				SAN CARLOS
<STATE>				CA
<ZIP>				94070
<PHONE>				6502607120
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			999 SKYWAY ROAD
<STREET2>			SUITE 150
<CITY>				SAN CARLOS
<STATE>				CA
<ZIP>				94070
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Lion Biotechnologies, Inc.
<DATE-CHANGED>			20131015
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Genesis Biopharma, Inc
<DATE-CHANGED>			20100319
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		FREIGHT MANAGEMENT CORP
<DATE-CHANGED>			20080128
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		8-A12B/A
<SEQUENCE>	1
<FILENAME>	v471509_8a12ba.htm
<DESCRIPTION>	8-A12B/A
<TEXT>
<HTML>
       Show <HTML>: 561 lines (widest: 316 characters) - 44K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001144204-17-038435 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Iovance Biotherapeutics, Inc. – ‘8-A12B/A’ on 7/26/17

On: Wednesday, 7/26/17, at 6:46pm ET · As of: 7/27/17 · Accession #: 1144204-17-38435 · File #: 1-36860

Amendment to Registration of a Class of Securities — Form 8-AFiling Table of Contents

Amendment to Registration of a Class of Securities — Form 8-A
Filing Table of Contents